JCR Pharmaceuticals and Alexion Reach Milestone in Neurodegenerative Program
September 19, 2025
JCR Pharmaceuticals Co., Ltd., a leading company in the field of specialty biopharmaceuticals that focuses on rare and genetic diseases, has achieved a major research
